Last reviewed · How we verify
Insulin (Humulin) — Competitive Intelligence Brief
marketed
Insulin
Insulin receptor (INSR)
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Insulin (Humulin) (Insulin (Humulin)) — University of Massachusetts, Worcester. Insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Insulin (Humulin) TARGET | Insulin (Humulin) | University of Massachusetts, Worcester | marketed | Insulin | Insulin receptor (INSR) | |
| Tepezza | TEPROTUMUMAB | Horizon Therapeutics Ireland | marketed | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | IGF-1R | 2020-01-01 |
| Adlyxin | LIXISENATIDE | Sanofi-Aventis Us Llc | marketed | Insulin Analog [EPC] | Glucagon-like peptide 1 receptor | 2016-01-01 |
| Tresiba | INSULIN DEGLUDEC | Novo Nordisk | marketed | Insulin Analog [EPC] | Insulin receptor | 2015-01-01 |
| Levemir | INSULIN DETEMIR | Novo Nordisk | marketed | Insulin Analog [EPC] | Insulin receptor | 2005-01-01 |
| Apidra | INSULIN GLULISINE | Sanofi | marketed | Insulin Analog [EPC] | Insulin receptor | 2004-01-01 |
| Novolog | INSULIN ASPART | Novo Nordisk | marketed | Insulin Analog [EPC] | Insulin receptor | 2000-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Insulin class)
- Eli Lilly and Company · 2 drugs in this class
- Hospital Universitario Dr. Jose E. Gonzalez · 2 drugs in this class
- Novo Nordisk A/S · 2 drugs in this class
- DreaMed Diabetes · 1 drug in this class
- Institute for Clinical and Experimental Medicine · 1 drug in this class
- Kinderkrankenhaus auf der Bult · 1 drug in this class
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 drug in this class
- Mackay Memorial Hospital · 1 drug in this class
- Biodel · 1 drug in this class
- American Heart Association · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Insulin (Humulin) CI watch — RSS
- Insulin (Humulin) CI watch — Atom
- Insulin (Humulin) CI watch — JSON
- Insulin (Humulin) alone — RSS
- Whole Insulin class — RSS
Cite this brief
Drug Landscape (2026). Insulin (Humulin) — Competitive Intelligence Brief. https://druglandscape.com/ci/insulin-humulin. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab